RARE

NASDAQ · Biotechnology

Ultragenyx Pharmaceutical In

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$25.02

+0.11 (+0.44%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 22 88%

Hold 3 12%

Sell 0 0%

Price Target

Analyst Price Target +197.5% upside

Low Target $68.49

Average Target $74.44

High Target $103.74

Current Price $25.02

Current
$25.02

Target
$74.44

$68.49 $74.44 avg $103.74

Scenario Analysis

Bear Case

$68.49

173.7%

Low target

Base Case

$74.44

+197.5%

Avg target

Bull Case

$103.74

+314.6%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$39.89

-37.3% from high

52-Week Low

$18.29

+36.8% from low

50-Day SMA

$26.56

-5.8% vs SMA

200-Day SMA

$31.06

-19.4% vs SMA

RSI (14)

37.4

Neutral

Target vs 52W High

$74.44

+86.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+5.4%
AMGN Amgen Inc	Hold	43	49%	$190.87	-52.7%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+179.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-42.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-46.0%
BIIB Biogen Inc	Buy	44	64%	$91.45	-55.7%